Tenon Medical, Inc. Deferred Costs, Noncurrent
Tenon Medical, Inc. (TNON) had Deferred Costs, Noncurrent of $69.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-03-27
- 2025-06-30: Deferred Costs, Noncurrent $69.00K.
- 2025-03-31: Deferred Costs, Noncurrent $321.00K.
- 2024-12-31: Deferred Costs, Noncurrent $431.00K.
- 2024-09-30: Deferred Costs, Noncurrent $431.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2025-06-30 | $69.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $321.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $431.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $431.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $439.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $439.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $798.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $644.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $168.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $67.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $25.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $428.00K 10-Q · filed 2022-06-09 |
| 2021-12-31 | $374.00K 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |